The Overall Survival of Patients With Unresectable HCC in Real-life
Recruiting
Observational Study
Hepatocellular Carcinoma
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 5,000 (estimated)
- Sponsor
- Humanity & Health Medical Group Limited · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma represents about 90% of primary liver cancers and constitutes a major global health problem. The pattern of HCC occurrence shows a significant geographical imbalance, with the highest incidence rates in East Asia (more than 50% of the cases occurring in China).…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with a diagnosis of unresectable hepatocellular carcinoma
* Able to comprehend and provide written informed consent in accordance with institutional guidelines.
Exclusion Criteria:
* Patients not willing to participate and/or give their written informed consent.
Contacts